AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,095,384 | -71.0% | 144,611 | -76.5% | 0.02% | -72.4% |
| Q1 2023 | $14,115,823 | +7.2% | 614,533 | +31.1% | 0.09% | -2.2% |
| Q4 2022 | $13,162,388 | -4.4% | 468,746 | -3.7% | 0.09% | -18.3% |
| Q3 2022 | $13,765,000 | +56.4% | 486,726 | +22.6% | 0.11% | +60.3% |
| Q2 2022 | $8,802,000 | -35.1% | 397,015 | -14.8% | 0.07% | -25.3% |
| Q1 2022 | $13,561,000 | +33.9% | 465,852 | +51.2% | 0.09% | +33.8% |
| Q4 2021 | $10,125,000 | -27.5% | 308,041 | +1.8% | 0.07% | -27.7% |
| Q3 2021 | $13,963,000 | +16.2% | 302,547 | +38.8% | 0.09% | +16.0% |
| Q2 2021 | $12,015,000 | +14.5% | 218,022 | +7.3% | 0.08% | 0.0% |
| Q1 2021 | $10,497,000 | +107.8% | 203,276 | +74.4% | 0.08% | +84.1% |
| Q4 2020 | $5,052,000 | +5.9% | 116,586 | -14.5% | 0.04% | -10.2% |
| Q3 2020 | $4,770,000 | +101.8% | 136,287 | +208.4% | 0.05% | +88.5% |
| Q2 2020 | $2,364,000 | +166.8% | 44,197 | +185.1% | 0.03% | +62.5% |
| Q4 2017 | $886,000 | -78.6% | 15,500 | -80.3% | 0.02% | -78.4% |
| Q3 2016 | $4,148,000 | +198.4% | 78,537 | +136.6% | 0.07% | +155.2% |
| Q2 2016 | $1,390,000 | – | 33,190 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |